-
Prevalence of Mycobacterium tuberculosis (Rifampicin-Resistant MTB) and Associated Risk Actors Among Pulmonary Presumptive TB Patients in Amhara, Ethiopia: 2015–2019 | SpringerLink
ID: LOZ8uRC61S
From: link.springer.com
-
Ultrasound in managing extrapulmonary randomized controlled two-center study | BMC Infectious Diseases | Full Text
ID: DZAwKaxtyX
From: bmcinfectdis.biomedcentral.com
-
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis NEJM
ID: rjWDVrtXnb
From: nejm.org
-
| Mycobacterium tuberculosis functional genetic altered drug sensitivity, and precision medicine
ID: r9u8uerkGM
From: frontiersin.org
-
Multidrug-resistant tuberculosis in Ethiopian settings its association with previous of anti-tuberculosis a systematic review and meta-analysis TB DIAH
ID: nlNP44IGUN
From: tbdiah.org
-
Reduced treatment delays for with TB co-infection through decentralised care and rapid Xpert MTB/RIF test | aidsmap
ID: zPNZOKDNJP
From: aidsmap.com
-
Integration TB-LAM and Xpert MTB/RIF (Xpert) testing to improve TB detection and shorten time to treatment initiation among People Living with HIV (PLHIV) in City, Zimbabwe
ID: XkjMv6hnjn
From: programme.aids2022.org
-
TropicalMed | Free Full-Text | Missing Cases of Bacteriologically TB/DR-TB the National Registers in West and North Sumatra Indonesia
ID: qXGvPAkFNO
From: mdpi.com
-
Figure 5 - Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert Latvia - Volume 22, Number 3—March 2016 - Emerging Infectious Diseases journal - CDC
ID: VlNNF369Qi
From: wwwnc.cdc.gov
-
4.2 Adult and adolescent algorithms | Guidelines
ID: kadDde5Syq
From: medicalguidelines.msf.org
-
Weakening Tuberculosis Defenses May Speed Treatment Thwart Drug Resistance | Newsroom Cornell Medicine
ID: E5LluyQwur
From: news.weill.cornell.edu
-
Xpert MTB/RIF Ultra Is Highly for Diagnosis of Tuberculosis Lymphadenitis in a High-HIV Setting | Journal of Clinical
ID: R0uIUM2zP7
From: journals.asm.org
-
The value of flow urine lipoarabinomannan assay and empirical treatment in Xpert MTB/RIF ultra negative patients with presumptive TB: a prospective cohort study | Scientific Reports
ID: 63wYeajCKc
From: nature.com
-
Frontiers | Molecular Diagnosis of Drug-Resistant A Literature Review
ID: zWkgTQ2usC
From: frontiersin.org
-
Delay in and among adult multidrug resistant tuberculosis patients in Yangon Regional Tuberculosis Center, Myanmar: a cross-sectional study | BMC Health Research | Full Text
ID: R0Q1BH496b
From: bmchealthservres.biomedcentral.com
-
New agents for treatment of drug-resistant Mycobacterium - ScienceDirect
ID: TIrB0NwrU3
From: sciencedirect.com
-
Evaluation of Xpert MTB-RIF guided diagnosis and treatment rifampicin-resistant Indonesia: A retrospective cohort study | PLOS ONE
ID: nEU99AlYhi
From: journals.plos.org
-
Mind the gap – Managing tuberculosis the - eBioMedicine
ID: YGYS54qrKc
From: thelancet.com
-
Assay Procedure the MTB/RIF Two volumes of sample | Download Scientific Diagram
ID: PGXsP1NycU
From: researchgate.net
-
MRIGlobal - As a partner in the Mycobacterium tuberculosis (Mtb) Quality Assessment Program (TBQA), we evaluate technologies, research, and study trends that support improved response treatment. Read more in our
ID: TfigsLQAHC
From: facebook.com
-
Assessment of tuberculosis disease activity in infected with Mycobacterium tuberculosis and living HIV: A longitudinal cohort study - eClinicalMedicine
ID: EWnxjMa8Kw
From: thelancet.com
-
Juliana Furtado Gets the VPP Treatment - Mountain Bike Press Vital MTB
ID: hy5Jk3V5LM
From: vitalmtb.com
-
| Free | Diabetes-Associated Susceptibility to Contribution Hyperglycemia vs. Dyslipidemia
ID: s7Jw5FCuYl
From: mdpi.com
-
Phosphoenolpyruvate depletion mediates both growth arrest and drug in hypoxia | PNAS
ID: GYnpN3rh69
From: pnas.org
-
Estimated viable Mtb in sputum during the first 56 days treatment... Download Scientific Diagram
ID: FHUiAOS8V8
From: researchgate.net
-
Comprehensive gene profiling, tumor board (mtb) artificial intelligence the diagnosis and treatment of patients with rare adult cancers – EJP RD – Joint Programme on Rare Diseases
ID: Bz5cTSTNwD
From: ejprarediseases.org
-
Therapeutic strategies improve outcome in tuberculosis | Mucosal Immunology
ID: 4rz41qfuQ3
From: nature.com